Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1225 of 3284 entries
View as:

COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00654485 Org: User:
Start: 05/31/02 End: 02/28/05 Due: 02/28/06

Centralized Pan-Middle East Survey on the Under-treatment of Hypercholesterolemia, Sub-study for the Gulf States

Phase: N/A Priority: Normal
NCT ID: NCT01031277 Org: User:
Start: 11/30/09 End: 07/31/10 Due: 07/31/11

Relative Bioavailability Study to Compare Inhalation of Terbutaline Sulphate 1,5mg Via Turbuhaler M3 With Turbuhaler M2

Phase: N/A Priority: Normal
NCT ID: NCT02178059 Org: User:
Start: 08/31/14 End: 11/30/14 Due: 11/30/15

Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression

Phase: N/A Priority: Normal
NCT ID: NCT00883493 Org: User:
Start: 04/30/09 End: 03/31/11 Due: 03/31/12

Open-Label Extension of Other SZ1839 (Iressa) Trials

Phase: N/A Priority: Normal
NCT ID: NCT00635973 Org: User:
Start: 02/29/00 End: 10/31/03 Due: 10/31/04

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00603239 Org: User:
Start: 01/31/08 End: 07/31/09 Due: 07/31/10

Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

Phase: N/A Priority: Normal
NCT ID: NCT04609904 Org: User:
Start: 03/01/21 End: 03/20/25 Due: 03/20/26

Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01874353 Org: User:
Start: 09/03/13 End: 12/31/25 Due: 12/31/26

Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04222465 Org: User:
Start: 03/19/20 End: 11/13/20 Due: 11/13/21

An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT07041606 Org: User:
Start: 06/30/25 End: 06/30/27 Due: 06/30/28

Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia

Phase: N/A Priority: Normal
NCT ID: NCT03172702 Org: User:
Start: 09/04/17 End: 07/06/19 Due: 07/06/20

To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305

Phase: N/A Priority: Normal
NCT ID: NCT00689247 Org: User:
Start: 04/30/08 End: 05/31/08 Due: 05/31/09

Long-Term Follow-Up and Management Patterns of Patients With Acute Coronary Syndrome in Middle East and Africa

Phase: N/A Priority: Normal
NCT ID: NCT03362463 Org: User:
Start: 12/28/15 End: 04/02/20 Due: 04/02/21

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04644068 Org: User:
Start: 11/12/20 End: 03/03/27 Due: 03/03/28

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)

Phase: N/A Priority: Normal
NCT ID: NCT00297115 Org: User:
Start: 03/31/06 End: 08/31/08 Due: 08/31/09

Utilization of Fixed Combination (Budesonide/Formoterol and Salmeterol/Fluticasone and Beclomethasone/Formoterol) in Treatment of Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01327001 Org: User:
Start: 04/30/11 End: 06/30/11 Due: 06/30/12

Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871

Phase: N/A Priority: Normal
NCT ID: NCT02971293 Org: User:
Start: 12/15/16 End: 08/18/17 Due: 08/18/18

A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components

Phase: N/A Priority: Normal
NCT ID: NCT00819104 Org: User:
Start: 11/30/08 End: 08/31/09 Due: 08/31/10

Explorative Study of AZD1305 in Atrial Fibrillation Patients

Phase: N/A Priority: Normal
NCT ID: NCT00643448 Org: User:
Start: 03/31/08 End: 08/31/08 Due: 08/31/09

A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers.

Phase: N/A Priority: Normal
NCT ID: NCT03907969 Org: User:
Start: 10/09/19 End: 12/07/22 Due: 12/07/23

Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)

Phase: N/A Priority: Normal
NCT ID: NCT01190072 Org: User:
Start: 09/30/10 End: 03/31/11 Due: 03/31/12

Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status

Phase: N/A Priority: Normal
NCT ID: NCT02983799 Org: User:
Start: 12/22/16 End: 12/03/20 Due: 12/03/21

Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)

Phase: N/A Priority: Normal
NCT ID: NCT00970268 Org: User:
Start: 08/31/09 End: 10/31/10 Due: 10/31/11

Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01641081 Org: User:
Start: 06/30/12 End: 02/28/13 Due: 02/28/14

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

Phase: N/A Priority: Normal
NCT ID: NCT01095666 Org: User:
Start: 06/30/10 End: 03/31/13 Due: 03/31/14